Enhanced Neurotransmitter Detection with Biorecognition Element-Functionalized Organic Electrochemical Transistors
Authors: Milroy Craig , Coyle Victoria , Reed Eric , Grogg Matt , Nelson Tyler , Kim Steve 
Published: August 2024

The United States National Academies of Science and Engineering have issued a grand challenge to “reverse-engineer the brain”. Addressing this challenge requires a more complete understanding of how connections between individual neurons and groups of neurons are formed and maintained, as well as a more thorough elucidation of the signaling processes that drive neural network optimization. However, to achieve these goals, it is first necessary to develop the appropriate fundamental tools and protocols for adaptive biointerfacing, bottom-up neuroscience, and neuromodulation.
To address this challenge, our research team has developed neurotransmitter-specific biosensors based on organic electrochemical transistors (OECT), which are electrolyte-gated devices that permit large signal amplification, ionic-to-electronic signal transduction, and controllable variable resistance. Given that their porous channel materials enable volumetric interaction with the adjacent electrolyte, OECT offer increased detection sensitivity compared to other electrolyte-gated devices such as field-effect transistors (FET). Although these OECT devices have demonstrated utility in a wide range of applications, from neuromorphic computing to bioelectronic devices, they are still in an early stage of development.
We report enhanced electrochemical sensing of dopamine, mediated by functionalizing the OECT gate electrode with dopamine-specific biorecognition elements (BRE, i.e., aptamers). To optimize these devices, our team tested a variety of electrode functionalization approaches (e.g. alkane-thiol or silane chemistry, layer-by-layer, and covalent modification). The operational principle of BRE-functionalized OECT gate electrode biosensing is based on changes in gate electrode surface potential caused by target-binding to the BRE. When the target binds to the BRE, the event alters the capacitance at the surface of the functionalized gate electrode. The change in surface potential at the gate electrode shifts the applied potential on the OECT channel, which alters the doping state of the OECT channel. The channel materials are mixed ionic/electronic conductors, so changes in the doping state of the channel will directly affect the transconductance of the channel, which alters the OECT transfer characteristic and thereby permits sensing. The large transconductance of the OECT channel allows small changes in doping state to amplify the signal caused by binding of the target to the surface-attached BRE.
In this study, we directly compare the dopamine biosensing performance of BRE-functionalized gold electrodes tested in two different sensing configurations:
(i) traditional amperometric biosensor with a BRE-functionalized working electrode
(ii) OECT with BRE-functionalized gate electrode
We confirm the operational principles outlined above, and quantitatively assess the biosensing performance through a variety of analytical and electroanalytical techniques, such as cyclic voltammetry, open-circuit potentiometry, electrochemical impedance spectroscopy (EIS), square-wave and differential pulse voltammetry (DPV), and electrochemical quartz crystal microbalance (EQCM). We also compare the observed concentration-dependent changes in OECT transfer characteristics to the changes predicted by a theoretical analysis of surface potential.
Finally, we will present the steps we have taken to implement these devices within organ-on-a-chip systems, both for traditional neurotransmitter biosensing and to demonstrate the utility of our devices for studying the formation and longitudinal evolution of neural networks within in vitro neuronal colonies.